Clinical Trials Browser

Phase 2 × Carcinoma, Medullary × pasireotide × Clear all

NCT01625520 2016-04-25

SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer

Phase 2 Completed

Carcinoma, Medullary